Clinical and laboratory findings, comorbidities, burden and survival in patients with overlap syndrome i.e. comorbid chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea hypopnea syndrome (OSAHS).Effect of non-invasive positive airway pressure (NIV) treatment.
- Conditions
- G47.3J44.9Sleep apnoeaChronic obstructive pulmonary disease, unspecified
- Registration Number
- DRKS00012709
- Lead Sponsor
- Democritus University of Thrace, Medical School, Greece
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Consecutive patients diagnosed with both OSAHS (obstructive sleep apnea hypopnea syndrome) and COPD (chronic obstructive pulmonary disease), as assessed by full-overnight polysomnography (PSG) and pulmonary function tests (PFTs), respectively, will be included in the study. Included patients will receive the standard medical care with optimal bronchodilation, according to GOLD 2017 guidelines, and optimal non invasive positive airway pressure treatment (NIV).
Exclusion Criteria
1. Age < 40 years
2. Refusal to participate in the study
3. Inability to understand and cooperate with
treatment
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method